Results 81 to 90 of about 74,860 (159)

The comparison of inflammation markers in patients with non-valvular atrial fibrillation using warfarin and switched to apixaban. [PDF]

Pak J Med Sci
Duman OO, Alpaslan E.
europepmc   +1 more source

Direct oral anticoagulants versus vitamin K antagonists for postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Ahmed OAO, Abbas M, Ahmed AAO, Ibrahim MAA, Abakar MEM, Yasir E, Edris MEE, Ahmed RAO, Ahmed RAO, Babkir M, Abdulaziz MAM, Sota HA, Gilbert C, Eissa AA.   +13 more
europepmc   +1 more source

Burden and Determinants of Drug-Drug Interactions at Hospital Discharge: Warfarin as a Model for High-Risk Medication Safety. [PDF]

Clin Pract
Methaset K, Jedsadayanmata A.
europepmc   +1 more source

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation. [PDF]

Front Pharmacol
Reis HJ, Costa LBX, Martins GL, Duarte RCF, Costa LCM, Figueiredo EL, Silveira FR, Coelho NG, Carvalho MDG, Vieira LB, Reis EA, Gomes KB, Ferreira CN.   +12 more
europepmc   +1 more source

Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence. [PDF]

Cureus
Alqurain A, Alshridha TI, Al-Otaibi S, Al-Otaibi DF, Douba FM, Aldhobaib AI, Alammar N, Khubrani MM, Althobaiti W, Alwashmi RM, Al-Aklabi FA, Alfahhad LS, Alkhouaiter KS, Alharbi GA, Almutairi RO.   +14 more
europepmc   +1 more source

Temporal trends in stroke-prevention medication use in patients with atrial fibrillation and chronic obstructive pulmonary disease. [PDF]

Front Pharmacol
Shen CW, Kitikannakorn N, Chen CY, Sirichanchuen B, Jenraumjit R, Liao KM.   +5 more
europepmc   +1 more source

Uncertain benefit, certain harm: the anticoagulation paradox in hemodialysis-re-evaluation of stroke prevention and bleeding risk in end-stage kidney disease. [PDF]

Korean J Intern Med
Chung TW.
europepmc   +1 more source

Factors Affecting the Time in Therapeutic Range of Warfarin Anticoagulation Therapy in Patients with Atrial Fibrillation. [PDF]

Clin Appl Thromb Hemost
Luo X, Zhou Q.
europepmc   +1 more source

Leukocytoclastic Vasculitis Associated with Coumarin Derivatives: A Case Report. [PDF]

Hosp Pharm
Mahadevappa M, Jayaprakash Narayan H, Srinivasan BR, Ravishankar N.   +3 more
europepmc   +1 more source

Warfarin and bevacizumab suppress tumor progression in pancreatic ductal adenocarcinoma by targeting EGFR-PI3K-Akt signaling: inhibition of proliferation/migration and apoptosis induction. [PDF]

Transl Cancer Res
Chen J, Ju J, Wang J, Yang L.
europepmc   +1 more source